Weight Change–Adjusted Effects of Gastric Bypass Surgery on Glucose Metabolism: 2- and 10-Year Results From the Swedish Obese Subjects (SOS) Study

• Published in: Diabetes care Vol. 39; no. 4; pp. 625 - 631
• Main Authors: Sjöholm, Kajsa, Sjöström, Elisabeth, Carlsson, Lena M.S., Peltonen, Markku
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.04.2016
• Subjects: Adult; Blood Glucose - metabolism; Carbohydrate Metabolism; Diabetes; Female; Follow-Up Studies; Gastric Bypass; Gastrointestinal surgery; Glucose; Glycated Hemoglobin A - metabolism; Humans; Insulin - blood; Insulin Resistance; Male; Middle Aged; Obesity - blood; Obesity - surgery; Prospective Studies; Sweden; Weight control; Weight Loss
• ISSN: 0149-5992; 1935-5548; 1935-5548
• DOI: 10.2337/dc15-1407

It has been suggested that weight change-independent effects on fasting insulin and glucose levels are present after gastric bypass (GBP) but not after banding and vertical banded gastroplasty (VBG). We therefore evaluated weight change-adjusted effects of GBP, compared with restrictive surgical procedures, on long-term changes in fasting levels of glucose, insulin, and homeostatic model assessment of insulin resistance (HOMA-IR) in the Swedish Obese Subjects (SOS) study. Participants who completed the 2-year (n = 1,762) and/or the 10-year (n = 1,216) follow-up were divided into three weight change classes (weight loss >30%, 20-30%, or ≤20%), and by surgical method (banding, VBG, or GBP). Glucose, insulin, and HOMA-IR changes were analyzed in relation to weight change over 2 and 10 years. Analyses were performed in the full cohort and also in subgroups based on baseline glucose status. Within weight change classes, reductions in glucose, insulin, and HOMA-IR were similar in the three surgery groups both at 2 and at 10 years. Reductions in glucose, insulin, and HOMA-IR increased with increasing weight loss, and changes were typically related to weight change within each surgery group. Moreover, the association between weight change and change in glucose, insulin, or HOMA-IR did not differ between the surgery groups at 2 and 10 years. When patients were subdivided also by baseline glucose status, similar relationships between weight changes and changes in glucose, insulin, and HOMA-IR were observed. Even though weight loss-independent effects are important for short-term diabetes remission, our results suggest that degree of weight loss is more important for long-term reductions in fasting insulin and glucose than choice of bariatric surgery procedure.